Does Wegovy mess with your birth control?

Is there a known interaction between Wegovy and the pill?

A common worry is that because Wegovy slows gastric emptying, it must interfere with how the body absorbs oral contraceptives. That logic is understandable, but the clinical picture is more specific than that.

The interaction concern you may have read about applies most clearly to semaglutide's cousin, tirzepatide, not to semaglutide itself. NHS England's guidance on weight-management injections advises women on tirzepatide to add a non-oral method of contraception (such as condoms) for the first four weeks of treatment and for four weeks after each dose increase. No equivalent instruction appears for semaglutide. NHS inform Scotland's wording on this topic is consistent with that distinction.

That doesn't mean there's zero consideration. Any medicine that causes significant nausea or vomiting can, in principle, reduce the time a pill has to be absorbed — and that's a general contraceptive precaution, not one unique to GLP-1 medicines. If you vomit within two hours of taking an oral contraceptive, standard pill-guidance applies: follow the instructions in your pill's Patient Information Leaflet. The Wegovy prescribing information covers this at the level of its GI side effects rather than a direct drug interaction.

The bottom line: current evidence does not show semaglutide meaningfully reduces the contraceptive pill's effectiveness, but GI side effects during the early weeks of treatment are worth being aware of.

What does the MHRA say about contraception and GLP-1 medicines generally?

Regulators treat the contraception question seriously, even where no direct absorption interaction has been shown. The MHRA advises that women of childbearing age should use effective contraception throughout GLP-1 treatment and for a defined wash-out period afterwards, before trying to conceive. That guidance applies to semaglutide and other GLP-1 medicines as a class.

The reason isn't primarily about the pill losing potency. It's about the underlying risk: Wegovy is not recommended during pregnancy, and the data on fetal safety are limited. Preventing unintended pregnancy while on treatment is the clinical priority. NHS England's guidance on weight-management injections is explicit that women should discuss contraceptive choices with their clinical team before starting.

This matters practically for women who rely solely on the pill as contraception. Even without a pharmacokinetic interaction, having a conversation about backup methods at the start of treatment is good clinical practice. It is also the kind of thing a prescriber at a regulated service should raise proactively during your consultation, not something you should have to discover from a forum.

For a closer look at taking Wegovy alongside specific contraceptive methods, our related page covers the practical considerations in more detail.

Should you change your contraception before starting Wegovy?

Probably not automatically, but it depends on your situation. If you're on a combined pill and your GI side effects during the first few weeks of treatment are mild, the clinical picture is reassuring. If you experience significant vomiting early on (which is most likely in the first month or after a dose step) it's worth knowing your pill may not have been fully absorbed on those days, and acting accordingly.

Women using long-acting reversible contraception (implant, coil, injection) don't face this issue at all. These methods work independently of the gut and are unaffected by nausea or vomiting.

If you're considering how semaglutide interacts with different contraceptive types, the key variables are your method, your GI response to the medicine, and whether you are planning a pregnancy in the near future. A prescriber can map all three against your situation. That's the conversation that should happen at consultation, not afterwards.

Women who are pregnant, breastfeeding, or actively trying to conceive should not start Wegovy. Under-18s are not a licensed population for this medicine either. These are firm clinical limits, not caveats.

Pricing and access information for private treatment is on our Wegovy access page, if that's useful context. The appropriate place to explore whether treatment is right for you is a clinical consultation, not a cost comparison.

If you have questions about our prescribers' approach to medicines reviews, our clinical team page gives a sense of who is reviewing consultations. And our FAQs cover the most common questions about the process. When you're ready, start your free consultation and a GPhC-registered prescriber will review your answers the same day.